Correction: Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.

Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jäger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd; Möller, Hans-Jürgen

Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jäger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd; Möller, Hans-Jürgen.

Afiliação

Schennach R; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Riedel M; Schoen Clinic Roseneck, Prien am Chiemsee, Germany.
Spellmann I; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Musil R; Psychiatric Clinic Rodewisch, Rodewisch, Germany.
Obermeier M; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Jäger M; Psychiatric Clinic, Stuttgart, Germany.
Bottlender R; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Schmauss M; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Laux G; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
Möller HJ; Psychiatric Clinic, District Hospital Kempten, Kempten, Germany.

Pharmacopsychiatry ; 52(4): e1, 2019 Jul.

Article em En | MEDLINE | ID: mdl-32102096

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google